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Anti-inﬂammation activityAbstract To investigate the anti-cancer properties of soil-borne actinobacteria, MJM 8637, the
glutathione S-transferase pi (GST-pi) assay, anti-tumor necrosis factor (TNF)-a assay, the level
of antioxidant potential by DPPH radical scavenging activity, NO scavenging activity, and
ABTS radical scavenging activity in ethyl acetate extract were determined. The 16S rDNA sequenc-
ing analysis revealed that Streptomyces sp. strain MJM 8637, which was isolated from Hambak
Mountain, Korea, has 99.5% similarity to Streptomyces atratus strain NBRC 3897. The physiolog-
ical and the morphological characteristics of the strain MJM 8637 were also identiﬁed. The ethyl
acetate extract of MJM 8637 inhibited TNF-a production approximately 61.8% at concentration
100 lg/ml. The IC50 value of the strain MJM 8637 extract on GST-pi was identiﬁed to be
120.2 ± 1.6 lg/ml. In DPPH, NO, and ABTS radical scavenging assays, the IC50 values of the
strain MJM 8637 extract were found to be 977.2 lg/ml, 1143.7 lg/ml, and 454.4 lg/ml, respectively.
The ethyl acetate extract of the strain MJM 8637 showed 97.2 ± 1.3% of cell viability at 100 lg/ml
in RAW 264.7 cell viability assay. The results obtained from this study suggest that the ethyl acetate
extract of Streptomyces sp. strain MJM 8637 could be considered as a potential source of drug for
GST-pi inhibition and anti-inﬂammation activity of Streptomyces sp. strain MJM 8637 745the cancers that have multidrug resistance with its GST-pi inhibition and anti-inﬂammation activ-
ities, and low cytotoxicity.
ª 2015 TheAuthors. Production and hosting by Elsevier B.V. on behalf ofKing SaudUniversity. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Today, cancer is a growing worldwide problem. The
GLOBOCAN reports that the number of new cancer cases
was 14.1 million and deaths caused by cancer were 8.2 million
in 2012 (Wild, 2014). In the countries of the Eastern
Mediterranean Region (EMR) of the World Health
Organization (WHO), the increase of new cancer cases is esti-
mated that from 555,000 to 819,000 by 2025 (Hofseth and
Ying, 2006). For prevention and treatment of cancer, a large
number of anti-cancer agents have developed from natural
plants, microorganisms and marine life (Wang et al., 2012).
However, there is no perfect anti-cancer agent against dissem-
inated cancer, because of resistance to a broad range of anti-
cancer drugs of cancer cells. The most common reason for
acquisition of drug resistance is active transporter systems that
detect and emit anti-cancer drugs from cancer cells, but induc-
tion of drug-detoxifying mechanisms also play a crucial role in
acquired anti-cancer drug resistance (Gottesman, 2002).
Glutathione transferases (GSTs; also known as glutathione
S-transferase; EC 2.5.1.1.8) are a multi-gene superfamily of
isoenzymes ubiquitously present in most living organisms.
These enzymes catalyze the nucleophilic addition of glu-
tathione (c-Glu-Cys-Gly; GSH) to a variety of electrophilic
compounds (Hayes et al., 2005; Laborde, 2010) and the result-
ing GSH conjugated compounds are exported from cells by
ATP-binding cassette (ABC) transporters (Gong et al., 2012).
The GSTs are classiﬁed as three major families, cytosolic,
mitochondrial, and microsomal, and cytosolic GSTs are sorted
into seven classes, a (alpha), l (mu), p (pi), r (sigma), h (theta),
x (omega), and f (zeta) (Mannervik et al., 2005). Recent stud-
ies revealed that expression level of GST-pi is elevated in var-
ious cancer cells that have multidrug resistance to anti-cancer
drugs, and suggested inhibition of GST-pi can be a solution to
overcome multidrug resistance of cancer cells (Backos et al.,
2012; Lu et al., 2011; Mukanganyama et al., 2002; Rolland
et al., 2010; Wang et al., 2011).
Recent studies revealed that chronic inﬂammation increases
genomic damage, disruption of DNA repair systems, inhibi-
tion of apoptosis, and the promotion of angiogenesis and inva-
sions, and all of these processes may lead to the initiation and
progression of cancers (Hofseth and Ying, 2006), and also dis-
played that anti-inﬂammatory agents are useful in the treat-
ment of a variety of cancers (Garcı´a-Lafuente et al., 2009;
Liu et al., 2010, 2014; Rayburn et al., 2009; Wang and
DuBois, 2013).
Streptomyces, which is the largest genus belonging to the
phylum actinomycetes, is Gram-positive ﬁlamentous bacteria
and they have very high genomic G+C contents (Euze´by
2008; Ka¨mpfer 2006). Most Streptomyces species show a com-
plex life cycle. They form substrate hyphae, which are multicel-
lular and ﬁlamentous, and in the next stage, aerial hyphae,
which are a second ﬁlamentous cell type, are produced into
the air from the substrate hyphae. The aerial hyphae aredivided into prespore compartments, and these prespores
developed to mature spores via maturation steps (Elliot
et al., 2008).
The actinomycetes is a dominant group in the soil and a
large number of actinomycetes have already been isolated from
soil and studied (Kuster, 1968; Muiru et al., 2008). Over 75%
of all antibiotics have been produced from actinomycetes, and
among them, approximately 80% are discovered from the
genus Streptomyces (Kieser et al., 2000; Thakur et al., 2009;
Tiwari and Gupta, 2012). Moreover, many anti-cancer drugs
(migrastatin, bleomycin, doxorubicin, etc.) have been discov-
ered from Streptomyces strains (Arcamone et al., 1969; Shan
et al., 2005; Umezawa et al., 1966). So, the genus
Streptomyces can be a useful natural resource for screening
of novel anti-cancer agent.
In this study, we isolated one Streptomyces strain MJM
8637 from mountain forest soil in Korea and identiﬁed the cul-
tural and phylogenetic characteristics of the strain MJM 8637.
To investigate anti-cancer properties of the strain MJM 8637,
GST-pi enzyme inhibition assay and TNF-a production assay,
which is for anti-inﬂammation test, were conducted.
Additionally, antioxidant activities of the ethyl acetate
(EtOAc) extract of strain MJM 8637 were also tested through
a series of in vitro tests such as reducing power measurement,
nitric oxide (NO) scavenging activity, ABTS (2,20-azino-bis(3-
ethylbenzothiazoline-6-sulfonic acid) free radical scavenging
activity), and DPPH (1,1-Diphenyl-2-picrylhydrazyl) radical
scavenging activity.
2. Materials and methods
2.1. Chemicals
The following reagents and solvents were purchased from
Sigma–Aldrich: ascorbic acid, 1,1-Diphenyl-2-picrylhydrazyl
(DPPH), 3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyltetrazolium
bromide (MTT), 2,2-azino-bis(3-ethylbenzothiazoline-6-sulfo
nic acid) (ABTS), potassium ferricyanide, trichloroacetic acid,
ferric chloride, sodium nitroprusside, sulfanilamide, phospho-
ric acid, naphthyl ethylenediamine dihydrochloride, sodium
nitrite, and Folin–Ciocalteu’s phenol.
2.2. Isolation of Streptomyces from mountain forest soil
The soil samples were collected from Hambak mountain,
Gyeonggi-do province, Korea (latitude 37 120 51.0000 N, longi-
tude 127 110 20.0000 E), in September, 2007. To collect the soil
samples, 3 cm of the soil surface was removed and the samples
were dug up from a depth of 20 cm. For isolation of
Streptomyces from the soil samples, 1000 mg of the soil was
suspended in 50 ml of deionized water, and then it was vor-
texed for 5 min. The soil–water suspension was allowed to set-
tle, and serially diluted up to 104. Then, an aliquot of 0.2 ml
of each dilution was spread on glucose-yeast extract–malt agar
746 S.-K. Lee et al.(GYM; medium 65; DSMZ) and Bennet’s agar (BN; medium
548; DSMZ), and incubated at 28 C for 7 days. Repeated
streaking on GYM and BN agar plates led to puriﬁed bacterial
colonies that showed an actinomycetes-like appearance.
2.3. Morphological identiﬁcation of the strain MJM 8637
Morphological identiﬁcation of the strain MJM 8537 was per-
formed according to the traditional morphological criteria
including characteristics of colonies on the plate, the presence
of aerial mycelium, spore mass color, distinctive reverse colony
color, and diffusible pigment (Goodfellow and Cross, 1984).
The cultural characteristics of the strain MJM 8637 were
observed after incubation for 7 days on 4 different media,
yeast extract–malt extract agar (ISP-2), oatmeal agar (ISP-3),
salt-starch agar (ISP-4), and glycerol–asparagine agar (ISP-5).
2.4. Physiological characteristics
Carbon source utilization pattern of the strain MJM 8637 was
identiﬁed according to the methods of Gottlieb (1961). The
isolated strain was grown on the basal medium, which was
composed of the following: KH2PO4, 2.38 g; KH2PO4Æ3H2O,
5.65 g; MgSO4Æ7H2O, 1 g; (NH4)2SO4, 2.64 g; trace element
solution, 6.25 ml; agar, 15 g; and distilled water, 1 l. The trace
element solution contained the following: CuSO4Æ3H2O,
102 mg; FeSO4Æ7H2O, 176 mg; MnCl2Æ4H2O, 126 mg;
ZnSO4Æ7H2O, 24 mg; and distilled water, 100 ml.
2.5. DNA isolation and 16S rDNA sequencing
Genomic DNA of the strain MJM 8637 was isolated using
Bacterial Genomic DNA isolation kit (Corebio, Korea), fol-
lowing the manufacturer’s manual. PCR ampliﬁcation of the
16S rDNA gene was conducted with primer set 27F/1492R
(Lane, 1991). Ampliﬁed PCR products were sequenced using
an automatic sequencer (ABI 3730XL; Applied Biosystems)
at Solgent, Daejeon, Korea.
2.6. Phylogenetic analysis
For identiﬁcation of taxonomic position of the strain MJM
8637, the 16S rDNA gene sequence (1417 bp) of strain MJM
8637 was aligned with sequences of related type strains by
using the CLUSTAL_X program (Thomson et al., 1997).
Phylogenetic analysis was performed with MEGA software
version 6.0 (MEGA6) (Tamura et al., 2013). Phylogenetic trees
were generated by Neighbor-Joining method (Saitou and Nei,
1987) using Tajima–Nei model (Tajima and Nei, 1984). The
topology of the phylogenetic tree was evaluated by bootstrap
resampling method of Felsenstein with 500 replicates
(Felsenstein, 1985).
2.7. Extraction of the secondary metabolites
For ﬂask fermentation, the spore suspensions of MJM 8637
were inoculated into 50 ml of BN medium and cultivated at
28 C for 48 h as seed culture. Then, 500 ll of seed culture
broth was collected and inoculated into 50 ml of BN mediumand cultivated at 28 C and 180 rpm for 6 days. The culture
broth was ﬁltered through ﬁlter paper (Whatman No. 1) and
the ﬁltered broth was extracted with two-volumes of ethyl acet-
ate twice. The EtOAc extract was dried in vacuum at 38 C and
200 mbar for various biological activity tests.
2.8. Cultivation of RAW 264.7 cells
RAW 264.7 macrophage cells were obtained from the Korea
Cell Line Bank (Seoul, Korea). The cells were cultivated in
DMEM medium (Hyclone, Logan, UT, USA), supplemented
with 10% fetal bovine serum (Hyclone, Logan, UT, USA)
and 1% penicillin/streptomycin (10,000 U/100 lg/ml, Gibco
Life Technologies, Carlsbad, CA, USA) in a 5% CO2 humid-
iﬁed atmosphere incubator at 37 C.
2.9. GST-pi enzyme assay
GST-pi activity wasmeasured by a photometric assay according
to previous report with few modiﬁcations (Mu¨ller et al., 2008).
To measure the rate of coupling of glutathione to chloro-
dinitrobenzene (CDNB), 50 ll of MJM 8637 EtOAc extract
was mixed with phosphate buffer and distributed into 96-well
plate. Ten microliters of GST-pi, 50 ll of reduced glutathione
solution (1 mM as ﬁnal concentration) and 50 ll of CDNB
(0.5 mM) were added to the each well, and incubated for
5 min. Absorbance was measured at 340 nm and the GST-pi
activity was calculated in lMCDNB conjugated/min/well with
extinction coefﬁcient (e= 9.6 mM1 cm1).
2.10. TNF-a production assay
The inhibitory effect of MJM 8637 EtOAc extract on TNF-a
production was determined using Enzyme Immuno Assay
Kits (BD Biosciences, USA) according to manufacturer’s
instructions. The RAW 264.7 macrophage cells (1 · 105 -
cells/well) were cultured in 96-well plates, and then pre-
incubated with different concentrations of MJM 8637 EtOAc
extract for 2 h. After pre-incubation, LPS was treated to each
well to stimulate TNF-a production and incubated for 6 h. The
supernatant was transferred to the well plates, which are
coated with TNF-a antibody, and absorbance was measured
at 450 nm with an ELISA plate reader (Tecan; Inﬁnite pro
2000, Switzerland).
2.11. Antioxidant assays
2.11.1. Reducing power assay
The reducing power measurement was conducted according to
a method of Oyaizu (1986) with slight modiﬁcations. The
EtOAc extract of MJM 8637 was diluted at various concentra-
tions and 1 ml of each dilution was mixed with 0.1 ml of 1%
potassium ferricyanide. The mixture was incubated at 50 C
for 20 min. After cooling, 0.1 ml of 1% trichloroacetic acid
was added to the mixture, and then the upper layer of mixture
was mixed with 0.1% ferric chloride. Finally, absorbance of
the mixtures was measured at 700 nm using spectrophotome-
ter. In this assay, the higher absorbance values of the reaction
mixture indicate an increase in the reducing power.
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The DPPH radical scavenging assay was carried out according
to the modiﬁed method of Diaz et al. (2012). EtOAc extracts of
the strain MJM 8637 were diluted with ethanol, 10 ll of dilu-
tion was distributed into a 96-well plate. To each well, 190 ll
of DPPH ethanol solution was added and allowed to react at
room temperature for 30 min. The absorbance was measured
at 550 nm by microplate reader.
The DPPH radical scavenging capability was calculated by
the following equation: DPPH radical scavenging activity
(%) = [(A0  A1)/A0] · 100, where A0, and A1 are the absor-
bance of control (blank) and the reaction system of sample
or ascorbic acid.
2.11.3. Nitric oxide (NO) scavenging activity
The nitric oxide scavenging activity of MJM 8637 EtOAc
extract was determined according to the method of Marcocci
et al. (1994) with slight modiﬁcations. One milliliter of
EtOAc extract was mixed with 1 ml of sodium nitroprusside
(5 mM) and the mixture was incubated at 25 C for 3 h.
After the incubation, 50 ll of Griess reagent (1% sulfanil-
amide, 2% phosphoric acid, and 0.1% of napthylenediamine
dihydrochloride) was added to the sample solution. The NO
scavenging activity was measured at 540 nm and referred to
the absorbance of standard solutions of sodium nitrite salt
treated in the same way with Griess reagent.
The NO radical scavenging capability was determined by
using the same equation that was used to calculate DPPH
scavenging activity.2.11.4. ABTS free radical scavenging assay
ABTS free radical scavenging assay was performed using the
method by Zhishen et al. (1999) with modiﬁcations. ABTS, 2
,20-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammo-
nium salt was dissolved in deionized water to a 7 mM concen-
tration. ABTS radical cation (ABTS+) was produced by
reacting ABTS solution with 2.45 mM potassium persulfate
(K2S2O8) and storing in the dark at room temperature for
12–16 h. The ABTS radical solution was diluted to an absor-
bance of 0.7 at 734 nm. 10 ll of MJM 8637 EtOAc extracts
were distributed into 96-well plate. To each well, 190 ll of
ABTS radical solution was added and incubated for 3 min at
room temperature. The absorbance was measured at 734 nm
by microplate reader. ABTS+ scavenging activity was deter-
mined using the same equation that was used to calculate
DPPH scavenging activity.2.12. Cytotoxicity assay
Cytotoxicity of the EtOAc extract was determined by
MTT cell viability assay, following the method by Mosmann
et al. (1983). RAW 264.7 cells were pated in a 96-well plate
(5 · 104 cells/well), and then incubated at 37 C in 5% CO2.
After 24 h, cells were treated with MJM 8637 EtOAc extracts
(ﬁnal concentration: 25, 50, and 100 lg/ml1) and incubated
for 24 h, and then the cells were treated with MTT solution
(5 mg/ml in PBS) for 4 h. The medium was removed and the
remaining cells were dissolved in DMSO. Then, the optical
density was measured at 570 nm by using microplate reader.The control (untreated) optical density of cells was taken as
100% of viability.
2.13. Statistical analysis
The data of all experiments were represented as Means ± SD
and were analyzed with Sigmaplot (version 12.5). Differences
were considered signiﬁcantly at p < 0.05.
3. Results
3.1. Morphological identiﬁcation of the isolated strain MJM
8637
The strain MJM 8637 formed dark gray colored aerial mass on
ISP-2, ISP-3, and ISP-4 agar medium. Color in media: soluble
pigments were not formed in ISP-2 and ISP-5 agar medium. In
ISP-3 and ISP-4 agar, dark grayish brown and yellowish gray
exopigments were found (Table 1).
3.2. Carbon source utilization of the isolated strain MJM 8637
Eight carbon sources (glucose, arabinose, rhamnose, fructose,
rafﬁnose, mannitol, sucrose, and inositol) were tested in this
study, and the strain MJM 8637 efﬁciently utilized fructose,
glucose, rafﬁnose, and rhamnose for growth and showed fair
growth with sucrose. Growth was not observed with arabi-
nose, inositol, and mannitol.
3.3. Molecular identiﬁcation of the isolated strain MJM 8637
The phylogenetic analysis revealed that the strain MJM 8637
belongs to the genus Streptomyces. The rooted phylogenetic
tree for MJM 8637 and related and representative type strains
of the genus Streptomyces demonstrated that this strain is most
closely related to Streptomyces atratus NBRC 3897 (Fig. 1).
The 16S rDNA gene sequence similarity between the strain
MJM 8637 and the type strain S. atratus NBRC 3897 was
99.5%.
3.4. GST-pi inhibition activity of the MJM 8637 EtOAc extract
The activity of GST-pi was inhibited with increasing concen-
trations of EtOAc extract of MJM 8637 as follows:
62.7 ± 15.8% at 7.8 lg/ml, 56.6 ± 6.8% at 15.6 lg/ml,
52.55 ± 11.4% at 31.25 lg/ml, 51.74 ± 12.6% at 62.5 lg/ml,
41.7 ± 1.8% at 125 lg/ml, 32.2 ± 3.1% at 250 lg/ml,
30.5 ± 6.6% at 500 lg/ml, and 24.6 ± 4.3% at 1000 lg/ml.
The IC50 value was found to be 120.2 ± 1.6 lg/ml (Fig. 2).
3.5. Anti-inﬂammation activity of the MJM 8637 EtOAc extract
Anti-inﬂammation activity of the EtOAc extract of MJM 8637
was determined via TNF-a production assay. For this assay,
1 lM of dexamethasone was used as a control reagent. The
TNF-a production was inhibited approximately 23.8 ± 5.2%
by 1 lM of dexamethasone, and 50 lg/ml and 100 lg/ml of
the EtOAc extract showed the inhibition rate 37.8 ± 15.3%
and 61.8 ± 2.4%, respectively (Fig. 3).
Table 1 Culture characteristics between the isolated strain MJM 8637 on different media.
Medium Growth Arial mycelium Substrate mycelium Pigmentation Aerial mass color
ISP-2 Moderate Poor Moderate No pigment Dark gray
ISP-3 Abundant Abundant Abundant Dark grayish brown Dark gray
ISP-4 Abundant Abundant Abundant Yellowish gray Dark gray
ISP-5 Abundant Abundant Abundant No pigment Gray
*ISP-2–5: International Streptomyces Project medium (Shirling and Gottlieb, 1966).
Figure 1 Phylogenetic tree based on the 16S rDNA sequences of showing afﬁliation of the strain MJM 8637 with closely related
members in GenBank. Phylogenetic trees were generated using MEGA version 6.0 with default parameters, Tajima–Nei model and the
Neighbor-Joining algorithm. The numbers at the branching prints are the percentages of occurrence in 500 bootstrapped tree.
Figure 2 GST-pi inhibition activity of the EtOAc extract from
Streptomyces sp. strain MJM 8637. Results represent the average
of three replicates (n= 3). Error bars represent standard
deviation.
Figure 3 Inhibition activity of the EtOAc extract from
Streptomyces sp. strain MJM 8637 on TNF-a production.
Dexamethasone was used as a positive control. Results represent
the average of three replicates (n= 3). Error bars represent
standard deviation.
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The potential antioxidant capacity of the extract can be mea-
sured by reducing power assay and it is indicated by changing
color. The color of the solution is changed into various shades
from green to blue, depending on the reducing power of antiox-
idant agents, and it can be measured at 700 nm. Fig. 4a shows
the reductive capabilities of the Streptomyces sp. strain MJM
8637 extract, and the highest reducing power and IC50 value
were found to be 1000 lg/ml and 1271.5 lg/ml, respectively.3.7. DPPH radical scavenging activity
The DPPH radical is scavenged by antioxidant compounds via
the donation of hydrogen ion, forming the non-radical DPPH.
The color of solution is changed from purple to yellow after the
reaction. The EtOAc extract of MJM 8637 showed the scaveng-
ing activities with increasing concentrations of extract as fol-
lows: 8.0 ± 2.7% at 31.25 lg/ml, 13.6 ± 1.7% at 62.5 lg/ml,
16.7 ± 3.4% at 125 lg/ml, 32.2 ± 2.9% at 250 lg/ml,
Figure 4 Results of antioxidant tests of the EtOAc extract from Streptomyces sp. strain MJM 8637 on (a) reducing power assay, (b)
DPPH radical scavenging assay, (c) NO scavenging assay, (d) ABTS free radical scavenging assay. Results represent the average of three
replicates (n= 3). Error bars represent standard deviation.
Figure 5 Cytotoxicity of the EtOAc extract from Streptomyces
sp. strain MJM 8637 on RAW 264.7 cells. Results represent the
average of three replicates (n= 3). Error bars represent standard
deviation.
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(Fig. 4b). The IC50 value was found to be 977.2 lg/ml.
3.8. NO scavenging activity
The EtOAc extract of MJM 8637 showed NO scavenging
activities with increasing concentration of extract as follows:
16.6 ± 1.9% at 31.25 lg/ml, 19.2 ± 4.6% at 62.5 lg/ml,
17.9 ± 1.1% at 125 lg/ml, 24.1 ± 8.7% at 250 lg/ml,
26.9 ± 1.6% at 500 lg/ml, and 37.2 ± 0.6% at 1000 lg/ml
(Fig. 4c). The IC50 value was found to be 1143.7 lg/ml.
3.9. ABTS free radical scavenging activity
The antioxidant capacity of the EtOAc extract of MJM 8637
was also evaluated according to the ABTS decolorization
method. The extract showed the scavenging activities with
increasing concentrations of extract as follows: 2.8 ± 3.2%
at 31.25 lg/ml, 4.3 ± 3.1% at 62.5 lg/ml, 5.2 ± 3.1% at
125 lg/ml, 10.9 ± 1.6% at 250 lg/ml, 52.2 ± 3.6% at
500 lg/ml, and 81.2 ± 4.5% at 1000 lg/ml (Fig. 4d). The
IC50 value was found to be 454.4 lg/ml.
3.10. MTT cell viability test
The cytotoxicity of the EtOAc extract of MJM 8637 at various
concentrations on RAW 264.7 cells was determined by the
MTT assay. Cell viabilities were 100 ± 12.6% at control(untreated), 102.9 ± 5.9%, 104.2 ± 5.2%, 96.8 ± 0.9%, and
97.2 ± 1.3% at 12.5 lg/ml, 25 lg/ml, 50 lg/ml, and 100 lg/ml
of the EtOAc extract of MJM 8637, respectively (Fig. 5).
4. Discussion
Recent studies have revealed that GST-pi has critical roles in
detoxiﬁcation of anti-cancer drugs in cancer cells and GST-
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tance of cancer cells. The close correlation between chronic
inﬂammation and the initiation of cancer has also been studied
well and the suppression of inﬂammation can be an effective
way for cancer prevention (Backos et al., 2012; Garcı´a-
Lafuente et al., 2009; Hofseth and Ying, 2006; Laborde,
2010; Liu et al., 2010, 2014, 2011; Mukanganyama et al.,
2002; Rayburn et al., 2009; Rolland et al., 2010; Wang et al.,
2011).
The increasing of cancer incidence and drug resistance of
cancer cells led us to investigation of novel anti-cancer com-
pound that has anti-GST-pi and anti-inﬂammation activities
from actinobacteria and Streptomyces strains. For the screen-
ing, we isolated actinomycetes from mountain forest soil in
Korea. The isolated actinobacteria, Streptomyces sp. strain
MJM 8637, exhibited GST-pi inhibition activity against and
reduction activity on the production of TNF-a. The 16S
rDNA sequencing revealed that Streptomyces sp. strain
MJM 8637 has 99.5% similarity with S. atratus NBRC 3897.
The strain MJM 8637 showed differences in carbon source uti-
lization to that of the strain NBRC 3897. A previous study
reported that the strain NBRC 3897 showed heavy growth
with glucose and rafﬁnose, good growth with rhamnose, fair
growth with fructose, and no growth with arabinose, mannitol,
sucrose, inositol (Shibata et al., 1961). The isolated strain
MJM 8637 showed good growth with fructose, glucose, rafﬁ-
nose, and rhamnose, fair growth with sucrose, and no growth
with inositol, mannitol, and sucrose.
The antioxidant activity assays demonstrated that the
antioxidant properties of the strain MJM 8637 EtOAc extract
are not powerful. The extract showed IC50 values of
977.2 lg/ml, 1143.7 lg/ml, and 454.4 lg/ml for DPPH, nitric
oxide, and ABTS free radical scavenging assays, respectively,
and in all antioxidant tests, the ascorbic acid, which was used
as a control, displayed IC50 values of 4.2 lg/ml, 8.0 lg/ml, and
31.7 lg/ml for DPPH, nitric oxide, and ABTS free radical
scavenging assays, respectively. According to these results,
the inhibition activities of the strain MJM 8637 EtOAc extract
on GST-pi and TNF-a do not seem to be related to the antiox-
idant activities.
The cytotoxicity of the strain MJM 8637 EtOAc extract
was determined by MTT assay on RAW 264.7 cells, and it
was measured as low cytotoxicity (97.2% of cell viability at
100 lg/ml).
In this study, Streptomyces sp. strain MJM 8637, a puta-
tively novel, was isolated from mountain forest soil and iden-
tiﬁed that the EtOAc extract of the strain MJM 8637 has
strong GST-pi inhibition and anti-TNF-a production activity.
Moreover, the low cytotoxicity of the extract gives a possibility
to develop the extract to an anti-cancer agent that can disable
the multidrug resistance of cancer cells. Further studies are
being performed for the puriﬁcation of single compound that
has anti-cancer activities from the EtOAc extract of
Streptomyces sp. strain MJM 8637.
5. Conclusions
In this study, we isolated and characterized Streptomyces sp.
strain MJM 8637, and have found the ethyl acetate extract
of the strain MJM 8637 has good glutathione S-transferase
pi inhibitory and anti-inﬂammatory activities, and lowcytotoxicity. The results could help to develop the drugs for
treating cancers with multidrug resistance.
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